Peter Sever
Professor
Faculty of Medicine
National Heart Lung Institute
United Kingdom
Biography
Peter Sever is Professor of Clinical Pharmacology and Therapeutics at Imperial College London, Honorary Consultant Physician at the Imperial Healthcare NHS Trust and Co-Director of the International Centre for Circulatory Health. After graduating from Cambridge, Professor Sever completed his training at St Mary’s Hospital Medical School. Following a succession of appointments in general medicine, cardiology and chest diseases, followed by lectureships in medicine and pharmacology, he became an Honorary Consultant Physician and Senior Lecturer in Medicine in the Medical Unit at St Mary’s Hospital in 1976. In 1980 he was appointed Professor of Clinical Pharmacology and Therapeutics at St Mary’s Hospital Medical School, which was subsequently incorporated into the Imperial College School of Medicine. During the past decade he established a major research programme in the pathogenesis and treatment of cardiovascular disease. He is Joint Editor in Chief of the Journal of the Renin-Angiotensin-Aldosterone System. He has been a member of the editorial boards of several journals, including the Journal of Hypertension, Journal of Human Hypertension and Clinical Science. Professor Sever is a past-president of the British Hypertension Society (1989-1991) and past president of the European Council for Blood Pressure and Cardiovascular Research. He is also a Fellow of the European Society of Cardiology and past Chairman of the Fellowships Committee of the British Heart Foundation. He received the Astra-Zeneca Award from the International Society for Hypertension in 2010 for contributions to the clinical pharmacology of hypertension. In 2011, he gave the Sir George Pickering Lecture to the British Hypertension Society, and was elected as Honorary Fellow of Trinity Hall, Cambridge.
Research Interest
hypertension
Publications
-
Mega JL, Stitziel NO, Smith JG, et al., 2015, Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials, The Lancet, Vol:385, ISSN:0140-6736, Pages:2264-2271